Pooled Source Plasma NAT for HIV-1An Update from the Bayer HIV-1 IND Study

Barbara Masecar

Bayer Corporation

Raleigh, NC

Blood Products Advisory Committee Meeting

67th Meeting

September 14, 2000

Next slide

Back to first slide

View graphic version